Document Detail


Cefaclor in the treatment of otitis media with effusion.
MedLine Citation:
PMID:  3865493     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A randomized clinical trial in which 91 children with chronic OME participated was performed. Cefaclor 20 mg/kg body weight b.i.d. was given to the treated group (n = 46) during 10 days preceding the day appointed for surgery. The control group (n = 45) remained untreated. On the day scheduled for surgery 24 (52%) of the treated cases had healed, compared to 5 (11%) of the untreated cases, a significant difference (p less than 0.001). The long term effects showed that in the treated group 18 of the 24 primarily healed remained unoperated at a median follow-up period of 20 months. In the untreated group two of the five that originally resolved later relapsed and were subjected to surgery.
Authors:
S Ernstson; M Anari
Related Documents :
3874573 - Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients i...
11530993 - Pre-treatment affinity for ljp 394 influences pharmacodynamic response in lupus patients.
12875733 - Clinical application of interventional techniques in the treatment of budd-chiari syndr...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Acta oto-laryngologica. Supplementum     Volume:  424     ISSN:  0365-5237     ISO Abbreviation:  Acta Otolaryngol Suppl     Publication Date:  1985  
Date Detail:
Created Date:  1986-01-22     Completed Date:  1986-01-22     Revised Date:  2008-02-13    
Medline Journal Info:
Nlm Unique ID:  0370355     Medline TA:  Acta Otolaryngol Suppl     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  17-21     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cefaclor / therapeutic use*
Cephalexin / analogs & derivatives*
Child
Child, Preschool
Chronic Disease
Drug Evaluation
Female
Follow-Up Studies
Humans
Infant
Male
Otitis Media with Effusion / drug therapy*
Recurrence
Chemical
Reg. No./Substance:
15686-71-2/Cephalexin; 53994-73-3/Cefaclor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of cefaclor on the nasopharyngeal flora in children with chronic OME.
Next Document:  Penetration of cefaclor to adenoid tissue and middle ear effusion in chronic OME.